Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06426992Recruiting
Open-label, single-arm trial in liver cancer, sponsored by Seoul National University Hospital. Primary endpoints: Technical Success Rate at 0 weeks and Local Tumor Recurrence Rate at 12 months. Started Apr 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06426992.